Quit Genius Raises $64 Million For Its Digital Addiction Treatment Clinic

Quit Genius, which provides a digital clinic for treating multiple addictions, raised $64 million in a Series B funding round co-led by Kinnevik and Atomico, with participation from Series A investors Octopus Ventures, Triple Point Ventures and Startup Health. The company will use the funds to fuel expansion of its platform across all 50 states.

The Quit Genius virtual clinical care model for addiction treatment combines virtual behavioral therapy with approved medication and connected devices. It offers programs for nicotine, alcohol, and opioid addiction. The average success rate for people in the Quit Genius tobacco program is 52%, which . . .